Johnson & Johnson (JNJ) EBITDA Margin (2009 - 2026)
Johnson & Johnson's EBITDA Margin was 32.68% in Q3 2026, down 4.04 percentage points from 36.72% a year earlier and down 3.27 percentage points from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) EBITDA Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Johnson & Johnson's EBITDA Margin was 33.51% through Sep 27, 2026, up 0.03 percentage points year-over-year; for FY2025, it was 34.90%, up 2.97 percentage points from FY2024.
- EBITDA Margin shows a four-year change of +2.33 percentage points (FY2021 to FY2025).
- In earlier years, EBITDA Margin was 31.92% in FY2024 (-2.14 pp), 34.06% in FY2023 (-0.58 pp), 34.64% in FY2022 and 32.57% in FY2021.
- Quarterly EBITDA Margin has moved between 24.40% (Q4 2024) and 41.58% (Q4 2022) over five years.
- Compared with a year earlier, EBITDA Margin has declined for three straight quarters, with an average year-over-year change of +0.25 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q4 2025 (a gain of 6.21 percentage points); the worst was Q4 2023 (a drop of 13.09 percentage points).
- Per Business Quant data, JNJ's EBITDA Margin in the three quarters before Q3 2026 was 35.95% (Q2 2026), 34.77% (Q1 2026) and 30.61% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 39.16% |
| 10 | Vertex Pharmaceuticals | 132.74 Bn | 104.74 Bn | 2.84 Bn | 39.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 32.68% |
| Jun 28, 2026 | 35.95% |
| Mar 29, 2026 | 34.77% |
| Dec 28, 2025 | 30.61% |
| Sep 28, 2025 | 36.72% |
| Jun 29, 2025 | 36.17% |
| Mar 30, 2025 | 36.33% |
| Dec 29, 2024 | 24.40% |
| Sep 29, 2024 | 30.63% |
| Jun 30, 2024 | 36.76% |
| Mar 31, 2024 | 36.12% |
| Dec 31, 2023 | 28.48% |
| Oct 1, 2023 | 35.45% |
| Jul 2, 2023 | 36.00% |
| Apr 2, 2023 | 36.35% |
| Jan 1, 2023 | 41.58% |
| Apr 3, 2022 | 30.85% |
| Oct 3, 2021 | 36.08% |
| Jul 4, 2021 | 34.49% |
| Apr 4, 2021 | 38.03% |
API Access
Johnson & Johnson EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();